Benexate (BEX) is an anti-ulcer agent used in the treatment of acid-related disorders. It is unique in its inability to form salts that are both non-bitter and soluble.[1][2]
Contents
1Medical uses
2Mechanism of action
3See also
4References
5Further reading
Medical uses
Benexate is approved from treatment of gastric ulcer in Japan.[3]
Mechanism of action
The mechanism of action of benexate involves promotion of prostaglandin synthesis, protein secretion, and blood flow stimulation in the gastrointestinal tract.[4]
See also
Famotidine
Powder diffraction
Sugar substitute
Crystal engineering
References
↑"Differential effect of benexate hydrochloride betadex on prostaglandin levels in stomach and inflammatory sites in rats". Japanese Journal of Pharmacology72 (2): 183–190. 1996. doi:10.1254/jjp.72.183. PMID 8912919.
↑"Studies of benexate CD: effect of inclusion compound formation on the antiulcer activity of benexate, the effective ingredient of benexate CD.". Folia Pharmacologica Japonica (91): 377–383. 1998.
↑"Benexate". Inxight Drugs. National Center for Advancing Translational Sciences. https://drugs.ncats.io/drug/O3PR2X907M.
↑"Benexate hydrochloride betadex modulates nitric oxide synthesis and cytokine expression in gastric ulcers". Experimental and Therapeutic Medicine12 (2): 573–580. 2016. doi:10.3892/etm.2016.3384. PMID 27446246.
Further reading
Rui Tamura, Mikiji Miyata, ed (2015). Advances in Organic Crystal Chemistry: Comprehensive Reviews 2015 (1st ed.). Springer Japan. doi:10.1007/978-4-431-55555-1. ISBN 978-4-431-55554-4. https://www.springer.com/gp/book/9784431555544.
0.00
(0 votes)
Original source: https://en.wikipedia.org/wiki/Benexate. Read more